In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients

J Chemother. 2018 Oct-Dec;30(6-8):338-341. doi: 10.1080/1120009X.2018.1522473. Epub 2018 Oct 30.

Abstract

Minimal inhibitory concentrations (MIC, mg/l) of ceftaroline and ceftobiprole were evaluated over 70 methicillin-resistant Staphylococcus aureus (MRSA) strains with vancomycin MIC ≥1 isolated in a paediatric hospital. The proportion of non-wild-type strains (MIC > epidemiological cut off) was 18% for ceftobiprole and 64% for ceftaroline. Only 1.4% of strains was resistant to ceftobiprole, and none to ceftaroline. These results are worrisome, since show the presence of non-negligible proportions of MRSA strains with high MIC values for ceftaroline and ceftobiprole in a setting where both drugs were never used.

Keywords: Ceftaroline; ceftobiprole; methicillin-resistant; minimal inhibitory concentrations; paediatrics.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ceftaroline
  • Cephalosporins / pharmacology*
  • Child
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Microbial Sensitivity Tests / methods
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • ceftobiprole
  • Vancomycin